Skip to content

Facebook page opens in new window Twitter page opens in new window Instagram page opens in new window Linkedin page opens in new window

PlusVitech

Desarrollamos tratamientos para devolver la esperanza a los pacientes

Home
About PlusVitech
Therapies
- Therapies
- Technology
Team
- Team
- Partners
- Advisors
Blog
Contact

Home
About PlusVitech
Therapies
- Therapies
- Technology
Team
- Team
- Partners
- Advisors
Blog
Contact

Tatiana Yglesias Ulloa

You are here:

Home
Teammate
Tatiana Yglesias Ulloa

MBA and MS Chemical Eng (MIT). 15 years Executive Director at Novartis. +1B€ in sales in EU/US.

Search the blog

Search:

Latest articles

PlusVitech, a Seville-based cancer drug development company, has been one of the winners of the World Business Angels Investment Forum (WBAF) 2024, held in Manama, Bahrain
PlusVitech Wins “Most Impactful Startup” Award at LifeTech Summit 2024
Nanoform and PlusVitech partner to repurpose aprepitant as a treatment for lung cancer
PlusVitech has been awarded the prestigious Seal of Excellence by the European Commission
PlusVitech has been selected for MassChallenge US Early Cohort 2023.

Categories

News
Sin categoría

PlusVitech develops effective and safe therapeutic treatments for Cancer with the purpose of restoring hope to patients who have no other option.

Find us on:

Facebook page opens in new window Twitter page opens in new window Linkedin page opens in new window Instagram page opens in new window

Where are we?
Sevilla/Spain office: C/ Herreros, 33
41510 - Mairena del Alcor, Sevilla
Boston office: 185 Alewife Brook Parkway, Ste 210
Cambridge, MA 02138
Contact
+34 600 620 284
info@plusvitech.com

Request for information

Por favor, deja este campo vacío.

Copyright 2021 -PlusVitech| Todos los derechos reservados | Web creada por Incrementa Marketing ¡Menta!

Home
About PlusVitech
Therapies
- Therapies
- Technology
Team
- Team
- Partners
- Advisors
Blog
Contact

Menu PRINCIPAL-Inglés